Volume 28, Issue Supplement_1, February 2022

Adverse Events Related to Therapy

EQUIVALENT ADVERSE OUTCOMES FOR HOME AND HOSPITAL-BASED INFUSIONS OF INFLIXIMAB IN CHILDREN AND ADOLESCENTS WITH INFLAMMATORY BOWEL DISEASE

Shivani Gupta and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S1, https://doi.org/10.1093/ibd/izac015.000

• Abstract
• View article

Animal Models: Pre-Clinical Treatment of Intestinal Inflammation

AHR EXPRESSION ON VIL1-EXPRESSING COLONIC EPITHELIAL CELLS IS ESSENTIAL FOR I3C-MEDIATED PROTECTION AGAINST COLITIS

Archana Saxena and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S1–S2, https://doi.org/10.1093/ibd/izac015.001

• Abstract
• View article

AUPHOS, A “FIRST-IN CLASS“ ORAL AGENT FOR CORRECTING METABOLIC DYSFUNCTION IN IBD

Lesley Wempe and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S2, https://doi.org/10.1093/ibd/izac015.002

• Abstract
• View article

AUPHOS, A NOVEL THERAPEUTIC THAT IMPROVES MITOCHONDRIAL FUNCTION AND AMELIORATES CHRONIC COLITIS

Rana Mohamed and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S2, https://doi.org/10.1093/ibd/izac015.003

• Abstract
• View article

CELL-AUTONOMOUS HEDGEHOG SIGNALING CONTROLS TH17 DIFFERENTIATION TO DRIVE INTESTINAL INFLAMMATION AND IS A DRUGGABLE TARGET FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE

Joachim Hanna and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S2–S3, https://doi.org/10.1093/ibd/izac015.004

• Abstract
• View article

CELLULAR AND MOLECULAR IMPACT OF THE MELANOCORTIN RECEPTOR AGONIST PL8177 IN DEXTRAN SODIUM SULFATE (DSS)-INDUCED COLITIS IN RATS

Priyanka Dhingra and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S3, https://doi.org/10.1093/ibd/izac015.005

• Abstract
• View article

DIET AND ITS MICROENVIRONMENT INFLUENCE THE HEALTH OF COLON

Sunil Thomas and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S3–S4, https://doi.org/10.1093/ibd/izac015.006

• Abstract
• View article

DISCOVERY OF IBD3540: A NOVEL GUT-RESTRICTED GLUTAMATE CARBOXYPEPTIDASE II INHIBITOR WITH ORAL ACTIVITY IN MOUSE COLITIS MODELS

Diane Peters and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S4, https://doi.org/10.1093/ibd/izac015.007

• Abstract
• View article

GENERATION OF ANTIGEN-SPECIFIC REGULATORY T CELLS BYLACTOBACILLUS SPECIES

Alexa Weingarden and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S4–S5, https://doi.org/10.1093/ibd/izac015.008

• Abstract
• View article

LACTOCOCCUS LACTIS DELIVERY OF SURFACE LAYER PROTEIN A PROTECTS MICE FROM COLITIS BY RE-SETTING HOST IMMUNE REPERTOIRE

Bikash Sahay

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S5, https://doi.org/10.1093/ibd/izac015.009

• Abstract
• View article

MTADV 5-MER PEPTIDE SUPPRESSES IBD PATHOLOGY AND UNVEILS A NEW POTENTIAL TARGET-SERUM AMYLOID A

David Naor and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S6, https://doi.org/10.1093/ibd/izac015.010

• Abstract
• View article

ORAL ADMINISTRATION OF NANOLIPOSOMES LOADED M13 MAY TREAT ULCERATIVE COLITIS AND COLITIS-ASSOCIATED CANCER WITHOUT CAUSING ANY SIDE EFFECTS

Dingpei Long and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S6–S7, https://doi.org/10.1093/ibd/izac015.011

• Abstract
• View article

TOFACITINIB TREATMENT PREVENTS POST-OPERATIVE RECURRENCE OF CROHN’S DISEASE MODELED BY ILEOCECAL RESECTION IN HLA-B27 TRANSGENIC RATS

Aurélie Blondeaux and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S7, https://doi.org/10.1093/ibd/izac015.012

• Abstract
• View article

Comparative Effectiveness Studies

ADVERSE CLINICAL OUTCOMES IN PATIENTS WITH CROHN’S DISEASE RECEIVING DIFFERENT SEQUENCES OF FIRST- AND SECOND-LINE BIOLOGIC TREATMENTS: FINDINGS FROM ROTARY

Noa Cleveland and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S7–S8, https://doi.org/10.1093/ibd/izac015.013

• Abstract
• View article

ADVERSE CLINICAL OUTCOMES IN PATIENTS WITH ULCERATIVE COLITIS RECEIVING DIFFERENT SEQUENCES OF FIRST- AND SECOND-LINE BIOLOGIC TREATMENTS: FINDINGS FROM ROTARY

Noa Cleveland and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S8–S9, https://doi.org/10.1093/ibd/izac015.014

• Abstract
• View article

DOSE ESCALATION OF BIOLOGIC THERAPIES IN BIOLOGIC TREATMENT-NAÏVE ADULT PATIENTS WITH ULCERATIVE COLITIS: RESULTS FROM THE ODESSA DATABASE STUDY

Niranjan Kathe and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S9–S10, https://doi.org/10.1093/ibd/izac015.015

• Abstract
• View article

EFFECTIVENESS OF ANTI-TNF THERAPY COMPARED TO IMMUNE MODULATOR FOR PREVENTION OF SURGICAL RECURRENCE IN PEDIATRIC CD

Matthew Egberg and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S10–S11, https://doi.org/10.1093/ibd/izac015.016

• Abstract
• View article

EFFICACY OF BIOLOGIC DRUGS IN SHORT-DURATION VERSUS LONG-DURATION INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW AND INDVIDUAL-PATIENT-DATA METANALYSIS OF RANDOMIZED CONTROLLED TRIALS

Shomron Ben-Horin and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S11, https://doi.org/10.1093/ibd/izac015.017

• Abstract
• View article

IDENTIFYING THE MOST EFFECTIVE TREATMENT ALGORITHM FOR THERAPIES TO TREAT MODERATE TO SEVERE ULCERATIVE COLITIS

Frank Scott and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S11–S12, https://doi.org/10.1093/ibd/izac015.018

• Abstract
• View article

SAFETY AND EFFECTIVENESS OF THE BNT162B2 MRNA COVID-19 VACCINE IN A NATIONWIDE COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Muhammad Khan and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S12–S13, https://doi.org/10.1093/ibd/izac015.019

• Abstract
• View article

Controlled Clinical Trials in Humans

ADDITIVE EFFECT OF PROBIOTICS ON 5-AMINOSALICYLIC ACID THERAPY IN PATIENT WITH ULCERATIVE COLITIS

Minjun Kim

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S13–S14, https://doi.org/10.1093/ibd/izac015.020

• Abstract
• View article

CORTICOSTEROIDS AND 5ASA VERSUS CORTICOSTEROIDS ALONE FOR ACUTE SEVERE ULCERATIVE COLITIS: A RANDOMIZED CONTROLLED TRIAL

Shomron Ben-Horin and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S14, https://doi.org/10.1093/ibd/izac015.021

• Abstract
• View article

MIRIKIZUMAB IMPROVES PATIENT ASSESSMENT OF DISEASE SEVERITY AND CHANGE IN DISEASE ACTIVITY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE

David Rubin and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S14–S15, https://doi.org/10.1093/ibd/izac015.022

• Abstract
• View article

MIRIKIZUMAB REDUCES ABDOMINAL PAIN IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE

Edward Loftus and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S15, https://doi.org/10.1093/ibd/izac015.023

• Abstract
• View article

POPULATION PHARMACOKINETICS AND PHARMACODYNAMICS OF OZANIMOD IN ULCERATIVE COLITIS

Daniel Tatosian and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S16, https://doi.org/10.1093/ibd/izac015.024

• Abstract
• View article

POPULATION PHARMACOKINETICS OF OZANIMOD AND ACTIVE METABOLITE CC112273 IN PATIENTS WITH ULCERATIVE COLITIS

Jun Shen and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S17–S18, https://doi.org/10.1093/ibd/izac015.025

• Abstract
• View article

SAFFRON AS AN ADJUVANT THERAPY IN ULCERATIVE COLITIS PATIENTS

Hassan Ashktorab and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S18, https://doi.org/10.1093/ibd/izac015.026

• Abstract
• View article

Cytokines, Signaling and Receptors

INTERLEUKIN-17 RECEPTOR SIGNALING TO PANETH CELLS HELPS MAINTAIN INTESTINAL INTEGRITY AFTER GAMMA RADIATION INDUCED INJURY

Cody Kempen and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S18, https://doi.org/10.1093/ibd/izac015.027

• Abstract
• View article

THE USE OF IMMUNOSTAINING IN BIOPSIES TO EVALUATE EXPRESSION PATTERN AND PATHOPHYSIOLOGY ROLES OF ONCOSTATIN M AND ITS RECEPTOR BETA IN PEDIATRIC INFLAMMATORY BOWEL DISEASE

Jonathan Beri and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S19, https://doi.org/10.1093/ibd/izac015.028

• Abstract
• View article

Diagnostics in IBD

AUTOMATIC BLEEDING AND ULCER DETECTION FROM LIMITED QUALITY ANNOTATIONS IN ULCERATIVE COLITIS

Safaa Al-Ali and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S19–S20, https://doi.org/10.1093/ibd/izac015.029

• Abstract
• View article

DEVELOPMENT AND VALIDATION OF A MACHINE LEARNING TOOL FOR EARLY DIAGNOSIS OF INFLAMMATORY BOWEL DISEASE IN THE PRIMARY CARE SETTING: A POPULATION BASED STUDY

Tahel Ilan Ber and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S20–S21, https://doi.org/10.1093/ibd/izac015.030

• Abstract
• View article

REAL-TIME CONTINUOUS REPORTING OF IBD BIOMARKERS IN SWEAT

Badrinath Jagannath and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S21, https://doi.org/10.1093/ibd/izac015.031

• Abstract
• View article

RISK FACTORS FOR DEVELOPMENT OF PROSTATE CANCER IN PATIENT WITH INFLAMMATORY BOWEL DISEASE (IBD)

Ishaan Jakhar and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S21–S22, https://doi.org/10.1093/ibd/izac015.032

• Abstract
• View article

THE ASSESSMENT OF MRE FINDINGS ACCORDING TO CDAI SCORE IN PATIENTS WITH CROHN’S DISEASE

Monika Zbroja and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S22, https://doi.org/10.1093/ibd/izac015.033

• Abstract
• View article

UTILITY OF FIBROSCAN IN ULCERATIVE COLITIS?

Shubham Jain and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S22–S23, https://doi.org/10.1093/ibd/izac015.034

• Abstract
• View article

WHEN CROHN’S COMES TO RADIOLOGIST- THE ROLE OF MR ENTEROGRAPHY (MRE) IN THE DIAGNOSIS OF PENETRATING CROHN’S DISEASE IN PEDIATRIC AND ADULT PATIENTS

Weronika Cyranka and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S23, https://doi.org/10.1093/ibd/izac015.035

• Abstract
• View article

Diet and IBD

AMINO ACID SENSING PATHWAYS IN INFLAMMATORY BOWEL DISEASE

Sumeet Solanki and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S23–S24, https://doi.org/10.1093/ibd/izac015.036

• Abstract
• View article

DIET-ASSOCIATED INFLAMMATION, PHYSICAL ACTIVITY, AND HEALTH-RELATED OUTCOMES IN ULCERATIVE COLITIS

Kelli DuBois and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S24, https://doi.org/10.1093/ibd/izac015.037

• Abstract
• View article

EFFECTIVENESS OF CROHN’S DISEASE EXCLUSION DIET FOR INDUCTION OF REMISSION IN CROHN’S DISEASE ADULT PATIENTS

Martyna Szczubelek and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S24–S25, https://doi.org/10.1093/ibd/izac015.038

• Abstract
• View article

EFFICACY OF A DIGITALLY DELIVERED PERSONALIZED ELIMINATION DIET FOR THE SELF-MANAGEMENT OF INFLAMMATORY BOWEL DISEASE AND IRRITABLE BOWEL SYNDROME

Samuel Jactel and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S25, https://doi.org/10.1093/ibd/izac015.039

• Abstract
• View article

LONG TERM OUTCOMES OF PARTIAL ENTERAL NUTRITION THERAPY IN CHILDREN WITH CROHN’S DISEASE

Srisindu Vellanki and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S26, https://doi.org/10.1093/ibd/izac015.040

• Abstract
• View article

MY SCD PROTOCOL - AN ONLINE, COMPREHENSIVE, REMOTELY-SUPERVISED PROTOCOL FOR IBD PATIENTS TO IMPLEMENT AN EFFECTIVE DIETARY INTERVENTION

Ali Arjomand and Rachelle Caviness

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S26–S27, https://doi.org/10.1093/ibd/izac015.041

• Abstract
• View article

NOVEL INSIGHTS INTO THE MECHANISM OF ACTION OF EXCLUSIVE ENTERAL NUTRITION IN CROHN’S DISEASE: PRE-CLINICAL STUDY IN A RODENT MODEL OF CROHN’S-LIKE COLITIS

Ramasatyaveni Geesala and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S27–S28, https://doi.org/10.1093/ibd/izac015.042

• Abstract
• View article

SELECTIVELY IMPROVEMENT OF THE RESPONSE OF IMMUNE CELLS TO OPPORTUNISTIC MICROORGANISMS: AN INNOVATIVE PROPOSAL FOR IBD FROM AN ANCIENT GRAIN

Sergio Pumarola Segura

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S28–S29, https://doi.org/10.1093/ibd/izac015.043

• Abstract
• View article

SIMPLE SUGAR TRIGGERS SPONTANEOUS COLITIS DEVELOPMENT INIL10^-/- MICE

Shahanshah Khan and Hasan Zaki

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S29, https://doi.org/10.1093/ibd/izac015.044

• Abstract
• View article

THE EFFECTS OF HIGH-FAT, LOW-FAT, AND SUCROSE-FREE DIETS ON MICE WITH INNATE IMMUNE MEDIATED COLITIS

Katelyn Ruley-Haase and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S29–S30, https://doi.org/10.1093/ibd/izac015.045

• Abstract
• View article

Disease Activity Assessment

ACUITY OF PEDIATRIC INFLAMMATORY BOWEL DISEASE ADMISSIONS PRE AND DURING THE COVID-19 PANDEMIC

Malika Waschmann and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S31, https://doi.org/10.1093/ibd/izac015.046

• Abstract
• View article

ADEQUACY OF SIGMOIDOSCOPY IN COMPARISION TO COLONOSCOPY TO ASSESS DISEASE ACTIVITY DURING FOLLOW UP IN PATIENTS WITH ULCERATIVE COLITIS

Sameet Patel and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S31–S32, https://doi.org/10.1093/ibd/izac015.047

• Abstract
• View article

CORRELATION OF FECAL, PLASMA, SERUM, AND SALIVARY CALPROTECTIN TO ENDOSCOPIC AND HISTOLOGIC OUTCOMES IN PATIENTS WITH CROHN’S DISEASE

Kendra Kamp and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S32, https://doi.org/10.1093/ibd/izac015.048

• Abstract
• View article

CORRELATION OF PUCAI BETWEEN MAYO ENDOSCOPIC AND GEBOES PATHOLOGY SCORES IN ASSESSING DISEASE ACTIVITY OF PEDIATRIC PATIENTS WITH UC AMONG HISPANICS AND NON-HISPANICS

Francisco Durazo and Sonia Michail

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S33, https://doi.org/10.1093/ibd/izac015.049

• Abstract
• View article

INFLAMMATORY BOWEL DISEASE RISK STRATIFICATION AND MANAGEMENT IN A COMMUNITY PRACTICE SETTING

Angelina Collins and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S33–S34, https://doi.org/10.1093/ibd/izac015.050

• Abstract
• View article

POINT-OF-CARE INTESTINAL ULTRASOUND FOR THE DETECTION OF POSTOPERATIVE CROHN’S DISEASE ENDOSCOPIC RECURRENCE

Michael Dolinger and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S34–S35, https://doi.org/10.1093/ibd/izac015.051

• Abstract
• View article

TOWARDS A COMMON VALIDATED METHODOLOGY FOR HISTOLOGIC MEASUREMENT OF MUCOSAL HEALING IN ULCERATIVE COLITIS: INTRODUCING A NEW PROJECT OF THE BIOMARKERS CONSORTIUM OF THE FOUNDATION FOR THE NIH

Gerard Honig

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S35, https://doi.org/10.1093/ibd/izac015.052

• Abstract
• View article

VALIDATION OF THE SIMPLIFIED ENDOSCOPIC MUCOSAL ASSESSMENT OF CROHN’S DISEASE (SEMA-CD) A NOVEL ENDPOINT TO ASSESS ENDOSCOPIC IMPROVEMENT WITH REAL WORLD DATA

Jeremy Adler and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S35–S36, https://doi.org/10.1093/ibd/izac015.053

• Abstract
• View article

Disease Complications

ANEMIA TREATMENT PATTERNS AND OUTCOMES AMONG A NATIONAL COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Carolyn Brooks and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S36–S37, https://doi.org/10.1093/ibd/izac015.054

• Abstract
• View article

BURDEN OF ILLNESS OF OSTEOPOROTIC FRACTURES COMPARED TO OTHER SERIOUS DISEASES AMONG IBD PATIENTS

Raseen Tariq and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S37, https://doi.org/10.1093/ibd/izac015.055

• Abstract
• View article

BURDEN OF NON-ALCOHOLIC FATTY LIVER DISEASE AMONG PATIENTS WITH CROHN’S DISEASE: ANALYSIS OF THE NATIONWIDE READMISSION DATABASE

Ahmed Abomhya and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S37–S38, https://doi.org/10.1093/ibd/izac015.056

• Abstract
• View article

CHRONIC COLITIS IN MICE INDUCES KIDNEY INJURY: TRANSLATIONAL IMPLICATIONS FOR IBD

Gloria Ducasa and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S38, https://doi.org/10.1093/ibd/izac015.057

• Abstract
• View article

COMPLICATIONS OF MYOCARDITIS IN INFLAMMATORY BOWEL DISEASE (IBD): A POPULATION-BASED COMPARATIVE STUDY BETWEEN ULCERATIVE COLITIS AND CROHN’S DISEASE

Neethi Dasu and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S38–S39, https://doi.org/10.1093/ibd/izac015.058

• Abstract
• View article

CROHN’S DISEASE AND ACUTE PANCREATITIS; ASSOCIATION, OUTCOMES, AND PREDICTORS OF 90-DAY READMISSION WITH ACUTE PANCREATITIS. INSIGHTS FROM THE NATIONWIDE READMISSION DATABASE

Ahmed Abomhya and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S39–S40, https://doi.org/10.1093/ibd/izac015.059

• Abstract
• View article

CURRENT VENOUS THROMBOEMBOLISM CHEMOPROPHYLAXIS PRACTICES AFTER SURGERY FOR IBD: SAVES-IBD TRIAL INITIAL REPORT

Stefan Holubar and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S40, https://doi.org/10.1093/ibd/izac015.060

• Abstract
• View article

ENDOSCOPIC STRICTUROTOMY – A NOVEL THERAPEUTIC MODALITY FOR IBD-RELATED STRICTURES: FIRST EUROPEAN EXPERIENCE

Martin Lukas and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S40–S41, https://doi.org/10.1093/ibd/izac015.061

• Abstract
• View article

MICROSCOPIC COLITIS IS ASSOCIATED WITH DECREASED BONE DENSITY: A SYSTEMATIC REVIEW AND META-ANALYSIS

Natapat Chaisidhivej and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S41, https://doi.org/10.1093/ibd/izac015.062

• Abstract
• View article

NON-IMMUNE MEDIATED MUSCULOSKELETAL DISEASE IN CROHN’S DISEASE PATIENTS BEING EVALUATED FOR INFLAMMATORY SPONDYLOARTHRITIS - A PILOT STUDY

Monica Schwartzman and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S41–S42, https://doi.org/10.1093/ibd/izac015.063

• Abstract
• View article

NON-IMMUNE MEDIATED MUSCULOSKELETAL DISEASE IN INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW OF THE LITERATURE

Monica Schwartzman and Sergio Schwartzman

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S42, https://doi.org/10.1093/ibd/izac015.064

• Abstract
• View article

PAIN IN INFLAMMATORY BOWEL DISEASE (IBD): DOES OPIOID USE PREDICT WORSE HOSPITAL OUTCOMES?

Neethi Dasu and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S42–S43, https://doi.org/10.1093/ibd/izac015.065

• Abstract
• View article

THE IMPACT OF CARDIAC ARRHYTHMIAS ON INFLAMMATORY BOWEL DISEASE (IBD)

Neethi Dasu and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S43, https://doi.org/10.1093/ibd/izac015.066

• Abstract
• View article

THE OPIOID EPIDEMIC: ASSESSING OUTCOMES OF OPIOID ABUSE IN CHRONIC INFLAMMATORY DISEASE (ULCERATIVE COLITIS VS CROHN’S DISEASE)

Neethi Dasu and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S43–S44, https://doi.org/10.1093/ibd/izac015.067

• Abstract
• View article

Epidemiology

COST-EFFECTIVENESS OF TOFACITINIB FOR THE TREATMENT OF MODERATE TO SEVERE ACTIVE ULCERATIVE COLITIS IN COLOMBIA

Fabio Gil and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S44, https://doi.org/10.1093/ibd/izac015.068

• Abstract
• View article

GEOGRAPHIC DIFFERENCES IN THE RISK OF SURGERY IN INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS

Tawnya Hansen and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S44–S45, https://doi.org/10.1093/ibd/izac015.069

• Abstract
• View article

GLOBAL HOSPITALIZATION TRENDS FOR CROHN’S DISEASE AND ULCERATIVE COLITIS: SYSTEMATIC REVIEW WITH TEMPORAL ANALYSES

Michael Buie and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S45–S46, https://doi.org/10.1093/ibd/izac015.070

• Abstract
• View article

IMPACT OF CURRENT AND FORMER SMOKING ON THE RISK OF ULCERATIVE COLITIS AMONG FAMILY HISTORY POSITIVE AND NEGATIVE INDIVIDUALS; EVIDENCE FOR GENE-SMOKING INTERACTION FROM LARGE SCALE POPULATION-BASED COHORT STUDY IN KOREA

Hyeong Sik Ahn and Hyun Jung Kim

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S46, https://doi.org/10.1093/ibd/izac015.071

• Abstract
• View article

INCIDENCE AND PREVALENCE OF PRIMARY SCLEROSING CHOLANGITIS: A META-ANALYSIS OF POPULATION-BASED STUDIES

Jared Cooper and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S46–S47, https://doi.org/10.1093/ibd/izac015.072

• Abstract
• View article

PREDICTORS OF CLINICAL RELAPSE AMONG PATIENTS WITH ULCERATIVE COLITIS IN ENDO-HISTOLOGIC REMISSION

Tanya Zeina and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S47–S48, https://doi.org/10.1093/ibd/izac015.073

• Abstract
• View article

SEROLOGICAL RESPONSES TO SARS-COV-2 VACCINATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE COHORT STUDY

Joshua Quan and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S48–S49, https://doi.org/10.1093/ibd/izac015.074

• Abstract
• View article

Epithelial Cell Biology/Function in Inflammation

DECREASED EXPRESSION OF NHE3 IN COLON CANCER EPITHELIUM IS ASSOCIATED WITH DNA DAMAGE, INCREASED LOCAL INFLAMMATION AND TUMOR GROWTH

Daniel Laubitz and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S49, https://doi.org/10.1093/ibd/izac015.075

• Abstract
• View article

EPITHELIAL DUOX2 ACTIVATION INCREASES GUT PERMEABILITY AND BACTERIAL TRANSLOCATION THAT IS RESCUED WITH BUTYRATE SUPPLEMENTATION

Hajar Hazime and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S49, https://doi.org/10.1093/ibd/izac015.076

• Abstract
• View article

ILEAL ENTEROCYTE BRUSH BORDER ABNORMALITIES ASSOCIATE WITH PROGRESSIVE DISEASE COURSE IN PEDIATRICS CROHN’S DISEASE

Yael Haberman and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S49–S50, https://doi.org/10.1093/ibd/izac015.077

• Abstract
• View article

MATRIX METALLOPROTEINASE (MMP-9) INDUCED INCREASE IN INTESTINAL EPITHELIAL TIGHT JUNCTION BARRIER IS MEDIATED BY EGFR ACTIVATION

Rana Al-Sadi and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S50, https://doi.org/10.1093/ibd/izac015.078

• Abstract
• View article

METHYLTRANSFERASE SMYD2 MODULATES THERAPEUTIC EFFECTS OF EPIDERMAL GROWTH FACTOR IN INFLAMMATORY BOWEL DISEASE

Xiaoqing Guan and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S50–S51, https://doi.org/10.1093/ibd/izac015.079

• Abstract
• View article

NEW OXPHOS REGULATING COMPOUND – AUPHOS – INCREASES MITOCHONDRIAL COMPLEXES EXPRESSION IN MURINE AND HUMAN INTESTINAL EPITHELIAL CELLS

Ahmed Elsayed and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S51, https://doi.org/10.1093/ibd/izac015.080

• Abstract
• View article

NOVEL CONTRIBUTIONS OF CLAUDIN-4 TO EPITHELIAL BARRIER REGULATION AND COLITIS

Nitesh Shashikanth and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S51–S52, https://doi.org/10.1093/ibd/izac015.081

• Abstract
• View article

OXPHOS DRIVES CRYPT FISSIONING REQUIRED FOR HEALING OF IBD ULCERS

Ahmed Abomhya and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S52, https://doi.org/10.1093/ibd/izac015.082

• Abstract
• View article

PLIN2 IS AN ARYL HYDROCARBON RECEPTOR TRANSCRIPTIONAL TARGET AND MAY CONTRIBUTE TO MUCOSAL RESTITUTION

Deanna Davis and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S53, https://doi.org/10.1093/ibd/izac015.083

• Abstract
• View article

PPI ADMINISTRATION CAUSES COLONIC TIGHT JUNCTION BARRIER DYSFUNCTION VIA INCREASE INENETROCOCCUS FECALIS

Meghali Nighot and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S53, https://doi.org/10.1093/ibd/izac015.084

• Abstract
• View article

Genomics and Gene Function

GENETIC OVERLAP BETWEEN INFLAMMATORY BOWEL DISEASE AND PARKINSON’S DISEASE IMPLICATES THE ROLE OF ADAPTIVE IMMUNE RESPONSE IN THEIR COMORBIDITY

Thomas Otten and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S53–S54, https://doi.org/10.1093/ibd/izac015.085

• Abstract
• View article

Innate and Mucosal Immunology and Immunity

A NEWLY DISCOVERED REGULATORY CD8 T CELL NETWORK HAS THE POTENTIAL TO REGULATE AND ELIMINATE PATHOGENIC CD4 T CELLS IN AUTOIMMUNE MEDIATED DISEASE OF THE GUT

Courtney Crane and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S55, https://doi.org/10.1093/ibd/izac015.086

• Abstract
• View article

ADHERENT-INVASIVEE. COLI PROMOTE ER STRESS TO SUPPORT IL23R-DRIVEN AGR2-DEPENDENT ILEOCOLITIS

Monica Viladomiu and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S56, https://doi.org/10.1093/ibd/izac015.087

• Abstract
• View article

ALTERED MICROBIAL BIOGEOGRAPHY IN INNATE IMMUNE-MEDIATED COLITIS

Antonia Boger-May and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S55–S56, https://doi.org/10.1093/ibd/izac015.088

• Abstract
• View article

CHRONIC COLITIS ALTERS BRAIN ACTIVITY BY INDUCING HMGB1-MEDIATED PYROPTOSIS IN MICE

Jonathon Mitchell and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S56, https://doi.org/10.1093/ibd/izac015.089

• Abstract
• View article

GENERATION OF HUMAN INTESTINAL ORGANOIDS CONTAINING TISSUE-RESIDENT IMMUNE CELLS

Kentaro Tominaga and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S57, https://doi.org/10.1093/ibd/izac015.090

• Abstract
• View article

INTERLEUKIN 21-INDUCED METABOLIC REPROGRAMMING DRIVES CD4 T CELL INFLAMMATORY RESPONSE DURING INTESTINAL INFLAMMATION

Adebowale Bamidele and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S58, https://doi.org/10.1093/ibd/izac015.091

• Abstract
• View article

MASS CYTOMETRY ANALYSIS OF CROHN’S DISEASE-LIKE PHENOTYPE OF THE ILEOANAL POUCH FOLLOWING ILEAL POUCH-ANAL ANASTOMOSIS FOR ULCERATIVE COLITIS

Siyan Cao and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S58–S59, https://doi.org/10.1093/ibd/izac015.092

• Abstract
• View article

NOD2 PROMOTES HOST DEFENSE AND RECOVERY INDUCING MACROPHAGE-MEDIATED INNATE LYMPHOID CELLS TYPE 3 ACTIVATION FOLLOWING FUNGAL INFECTION IN EXPERIMENTAL COLITIS

Morgan McAndrew and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S59, https://doi.org/10.1093/ibd/izac015.093

• Abstract
• View article

NOVEL FUNCTION OF MYELOID METHYLTRANSFERASE SMYD5 IN INFLAMMATORY BOWEL DISEASE PROGRESSION

Yuning Hou and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S59–S60, https://doi.org/10.1093/ibd/izac015.094

• Abstract
• View article

THE ROLE OF GROUP 3 INNATE LYMPHOID CELLS (ILC3) IN GM-CSF/CSF2RB-DEPENDENT INTESTINAL HOMEOSTASIS IN CROHN’S DISEASE

Ling-shiang Chuang and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S60, https://doi.org/10.1093/ibd/izac015.095

• Abstract
• View article

TNFAIP3 DRIVES COLITIS THROUGH DEATH CELL AND TNFα PRODUCTION

Alvaro Torres Huerta and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S61, https://doi.org/10.1093/ibd/izac015.096

• Abstract
• View article

Intestinal Inflammation, Fibrosis and Regeneration

A NOVEL MICROBIALLY-DERIVED PROTEIN CAN BE EXPRESSED INLACTOCOCCUS LACTIS AND DELIVERED ORALLY TO IMPROVE GUT BARRIER FUNCTION AND PREVENT FIBROGENESIS BY INTERACTING WITH THE EXTRACELLULAR MATRIX DURING GI INJURY

Chip La La Chat and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S61, https://doi.org/10.1093/ibd/izac015.097

• Abstract
• View article

A NOVEL ORALLY ACTIVE METABOLITE REVERSES CROHN’S DISEASE-ASSOCIATED INTESTINAL FIBROSIS

Hon Wai Koon

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S61–S62, https://doi.org/10.1093/ibd/izac015.098

• Abstract
• View article

ACTIVATION OF MK2 IN CROHN’S DISEASE-ASSOCIATED FIBROSIS: NEW TARGET FOR ANTI-FIBROTIC THERAPY

Marina Chulkina and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S62, https://doi.org/10.1093/ibd/izac015.099

• Abstract
• View article

EICOSATETRAYNOIC ACID REGULATES MITOCHONDRIAL AND EXTRA-CELLULAR MATRIX GENE EXPRESSION AND TISSUE STIFFNESS IN A HUMAN INTESTINAL ORGANOID MODEL OF ILEAL CROHN’S DISEASE

Ingrid Jurickova and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S62–S63, https://doi.org/10.1093/ibd/izac015.100

• Abstract
• View article

GPX3 IS REQUIRED TO MEDIATE PROTECTIVE EFFECTS OF GPX1 LOSS IN COLITIS

Koral Blunt and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S63, https://doi.org/10.1093/ibd/izac015.101

• Abstract
• View article

INCREASE IN MK2 ACTIVITY IN CROHN’S DISEASE: ROLE IN THE INFLAMMATORY ACTIVATION OF FIBROBLASTS

Marina Chulkina and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S63–S64, https://doi.org/10.1093/ibd/izac015.102

• Abstract
• View article

NIPEP-IBD; A SYNTHETIC PEPTIDE TARGETING NOVEL MOLECULE, INTEGRIN BETA 1, TO RESTITUTE INTESTINAL EPITHELIAL CELLS FOR INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT

Deogil Kim and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S64, https://doi.org/10.1093/ibd/izac015.103

• Abstract
• View article

TH17 CELLS PROMOTE INTESTINAL FIBROSIS THROUGH THE PRODUCTION OF AMPHIREGULIN

Wenjing Yang and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S64–S65, https://doi.org/10.1093/ibd/izac015.104

• Abstract
• View article

Microbial-Based Therapy

LACTOBACILLUS MURINUS ACTIVATES THE ARYL HYDROCARBON RECEPTOR TO ATTENUATE TNF-ALPHA-INDUCED PRO-INFLAMMATORY RESPONSES IN HUMAN INTESTINAL EPITHELIAL CELLS

Husnain Ahmed and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S65, https://doi.org/10.1093/ibd/izac015.105

• Abstract
• View article

RANDOMIZED, DOUBLE-BLIND, PLACEBO (PBO)-CONTROLLED, SINGLE- AND MULTIPLE-DOSE PHASE 1 STUDY OF VE202, A DEFINED BACTERIAL CONSORTIUM FOR TREATMENT OF IBD: SAFETY AND COLONIZATION DYNAMICS OF A NOVEL LIVE BIOTHERAPEUTIC PRODUCT (LBP) IN HEALTHY ADULTS

Jeffrey Silber and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S65–S66, https://doi.org/10.1093/ibd/izac015.106

• Abstract
• View article

SELECTION OF MICROBIOME-DERIVED PEPTIDES THROUGH MULTI-TECHNOLOGY META-ANALYSIS, BINDING, AND FUNCTIONAL ASSAYS, IDENTIFIES PEPTIDES WITH THERAPEUTIC POTENTIAL THAT MODULATE IMMUNE RESPONSES AND DISEASE

Michelle Lin and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S66, https://doi.org/10.1093/ibd/izac015.107

• Abstract
• View article

Microbiome

BRAIN FOG IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE, AND ASSOCIATION WITH USE OF PROBIOTICS

Apaar Dadlani and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S66–S67, https://doi.org/10.1093/ibd/izac015.108

• Abstract
• View article

COMPARING THE GUT METABOLOMIC PROFILES IN HISPANIC AND NON-HISPANIC PEDIATRIC ULCERATIVE COLITIS PATIENTS

Parastou Khalessi Hosseini and Sonia Michail

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S67, https://doi.org/10.1093/ibd/izac015.109

• Abstract
• View article

FECAL MICROBIOTA OF PEOPLE WITH CROHN’S DISEASE DOES NOT CHANGE WITH ILEOCECAL RESECTION

Daphne Moutsoglou and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S67–S68, https://doi.org/10.1093/ibd/izac015.110

• Abstract
• View article

INTESTINAL EPITHELIAL CELL-SPECIFIC CFTR KNOCKOUT MICE EXHIBIT FECAL MICROBIAL DYSBIOSIS

Sarah Young and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S68–S69, https://doi.org/10.1093/ibd/izac015.111

• Abstract
• View article

KLEBSIELLA PNEUMONIAE IN THE COLONIC MUCUS LAYER INFLUENCESCLOSTRIDIODES DIFFICILE PATHOGENESIS

Taylor Ticer and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S69, https://doi.org/10.1093/ibd/izac015.112

• Abstract
• View article

THE MICROBIAL LANDSCAPE OF ULCERATIVE COLITIS IN ENDOSCOPIC REMISSION

Sushrut Jangi and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S69–S70, https://doi.org/10.1093/ibd/izac015.113

• Abstract
• View article

THE SYNTHETIC GLYCAN KB295 OPTIMIZES MICROBIOME COMPOSITION AND FUNCTION IN ULCERATIVE COLITIS – RESULTS FROM A PROOF OF PRINCIPLE HUMAN STUDY

Jeffrey Meisner and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S70–S71, https://doi.org/10.1093/ibd/izac015.114

• Abstract
• View article

TRENDS IN ADMISSIONS, OUTCOMES AND FINANCIAL BURDEN OFC. DIFFICILE INFECTION RELATED HOSPITALIZATIONS AMONG INFLAMMATORY BOWEL DISEASE PATIENTS: A NATIONWIDE ANALYSIS

Muhammad Waqas Tahir and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S71, https://doi.org/10.1093/ibd/izac015.115

• Abstract
• View article

Natural History and Outcomes

CLINICAL FEATURES AND OUTCOMES OF PAEDIATRIC PATIENTS WITH ISOLATED COLONIC CROHN’S DISEASE: A MULTICENTRE STUDY FROM THE PAEDIATRIC IBD PORTO GROUP OF ESPGHAN

Tal Berger and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S71–S72, https://doi.org/10.1093/ibd/izac015.116

• Abstract
• View article

COMPARISON OF THE INFLAMMATORY BOWEL DISEASES PHENOTYPE AND COURSE IN THE ELDERLY- AND EARLY-ONSET PATIENTS

Bahar Saberzadeh-Ardestani and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S72, https://doi.org/10.1093/ibd/izac015.117

• Abstract
• View article

DEVELOPMENT AND VALIDATION OF THE CROHN’S DISEASE-HEALTH INDEX (CD-HI), A CLINICALLY-RELEVANT, DISEASE-SPECIFIC PATIENT-REPORTED OUTCOME MEASURE

Jamison Seabury and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S73, https://doi.org/10.1093/ibd/izac015.118

• Abstract
• View article

IMPACT OF TIMING OF INITIATION OF INFLIXIMAB ON THE RISK OF IBD-RELATED SURGERY AND COMPLICATIONS

Denise Young and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S73, https://doi.org/10.1093/ibd/izac015.119

• Abstract
• View article

INCIDENTALLY DIAGNOSED ASYMPTOMATIC CROHN’S DISEASE: LONG-TERM CLINICAL OUTCOMES OF UNTREATED PATIENTS

Ana Grinman and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S74, https://doi.org/10.1093/ibd/izac015.120

• Abstract
• View article

INFLAMMATORY BOWEL DISEASE IN APPALACHIA: AN INVESTIGATION INTO DISPARATE OUTCOMES WITHIN THE STATE OF KENTUCKY

Courtney Perry and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S74–S75, https://doi.org/10.1093/ibd/izac015.121

• Abstract
• View article

LONG TERM ADVERSE HEALTH OUTCOMES IN OFFSPRING FROM MOTHERS WITH INFLAMMATORY BOWEL DISEASE: A NATIONWIDE POPULATION BASED STUDY IN KOREA

Hyeong Sik Ahn and Hyun Jung Kim

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S75, https://doi.org/10.1093/ibd/izac015.122

• Abstract
• View article

OUTCOMES OF TOTAL PROCTOCOLECTOMY (TPC) WITH ILEAL POUCH ANAL ANASTOMOSIS (IPAA)

Jessica Petrov and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S75–S76, https://doi.org/10.1093/ibd/izac015.123

• Abstract
• View article

PREDICTORS AND OUTCOMES OF BIOLOGIC/IMMUNOSUPPRESSIVE THERAPY FOR PSC-ASSOCIATED IBD

Amr Sayed and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S76, https://doi.org/10.1093/ibd/izac015.124

• Abstract
• View article

RELATIONSHIP BETWEEN SELF-REPORTED SLEEP AND DISEASE ACTIVITY DIFFERS BASED ON ENDOSCOPIC OR CLINICAL DISEASE ACTIVITY MEASURES

Kendra Kamp and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S77, https://doi.org/10.1093/ibd/izac015.125

• Abstract
• View article

Omics for Prognosis, Therapeutic Selection, and Mechanisms

UHPLC-MS/MS-BASED PLASMA LIPIDOMICS REVEAL ALTERATIONS ASSOCIATED WITH EXCLUSIVE ENTERAL NUTRITION TREATMENT IN ADULT PATIENTS WITH ACTIVE CROHN’S DISEASE

Qingfan Yang and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S77–S78, https://doi.org/10.1093/ibd/izac015.126

• Abstract
• View article

Practice Management/Quality of Care/Quality Assurance

COMMUNICATING NEEDS AND FEATURES OF IBD EXPERIENCES (CONFIDE) SURVEY: BURDEN AND IMPACT OF BOWEL URGENCY ON PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS

Stefan Schreiber and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S79, https://doi.org/10.1093/ibd/izac015.127

• Abstract
• View article

CONCORDANCE BETWEEN REMISSION DEFINED BY PATIENTS VS PATIENT-REPORTED OUTCOME MEASURES IN INFLAMMATORY BOWEL DISEASE

Kendra Kamp and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S79–S80, https://doi.org/10.1093/ibd/izac015.128

• Abstract
• View article

CROHN’S DISEASE COMPLICATED BY ILEOSIGMOID FISTULA: ASSESSMENT AND MANAGEMENT UPDATE

Sarah Benammi and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S80–S81, https://doi.org/10.1093/ibd/izac015.129

• Abstract
• View article

EFFECTS OF DELAYED ENDOSCOPIES IN INFLAMMATORY BOWEL DISEASE PATIENTS DURING THE COVID-19 PANDEMIC

Karen Young and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S81, https://doi.org/10.1093/ibd/izac015.130

• Abstract
• View article

ENHANCED RECOVERY PROGRAMS: HOW ARE WE BENEFITTING PATIENTS WITH IBD?

Connie Shao and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S81–S82, https://doi.org/10.1093/ibd/izac015.131

• Abstract
• View article

EVALUATING THE IMPACT OF THE COVID-19 PANDEMIC ON URGENT MEDICAL ACCESS FOR PATIENTS WITH INFLAMMATORY BOWEL DISEASE AT A PRIVATE COMMUNITY GASTROENTEROLOGY PRACTICE

Michelle Kwon and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S82, https://doi.org/10.1093/ibd/izac015.132

• Abstract
• View article

IBD AND THE PATIENT-PROVIDER RELATIONSHIP: DOES TRUST IMPACT TELEMEDICINE UTILIZATION?

Meghna Katta and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S83, https://doi.org/10.1093/ibd/izac015.133

• Abstract
• View article

IBD MIMICS PRESENTED AT IBD LIVE: WHEN IT IS NOT INFLAMMATORY BOWEL DISEASE

Christopher Ward and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S83–S84, https://doi.org/10.1093/ibd/izac015.134

• Abstract
• View article

IMPLICATIONS OF ADOLESCENT AND PARENT PERCIEVED SKILL-BUILDING ON MISCARREID HELPING AND SELF-EFFICACY FOLLOWING A TRANSITION WORKSHOP FOR ADOLESCENTS WITH INFLAMMATORY BOWEL DISEASE

Malika Waschmann and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S84, https://doi.org/10.1093/ibd/izac015.135

• Abstract
• View article

IMPROVING THE VACCINATION RATES FOR IMMUNOSUPPRESSED PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Tony Cheng and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S84–S85, https://doi.org/10.1093/ibd/izac015.136

• Abstract
• View article

LOCAL IBD-EXPERTS DISSATISFACTION WITH BIOLOGIC MEDICATION AUTHORIZATION DENIALS - A SURVEY OF SPECIFIC CLINICAL SCENARIOS

Leah DeCoste and Randall Pellish

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S85, https://doi.org/10.1093/ibd/izac015.137

• Abstract
• View article

MEDICAL DECISION-MAKING AND EDUCATION RELATED TO OSTOMY SURGERY IN PEDIATRIC PATIENTS WITH IBD: QUALITATIVE THEMES FROM MULTIDISCIPLINARY PROVIDER FOCUS GROUPS

Jennie David and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S85–S86, https://doi.org/10.1093/ibd/izac015.138

• Abstract
• View article

SECURE ELECTRONIC DOCUMENT SIGNING UPTAKE IN BIOLOGIC PRESCRIBING FOR IMMUNE MEDIATED DISEASES

Sowmya Sharma and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S86, https://doi.org/10.1093/ibd/izac015.139

• Abstract
• View article

Quality of Life/Psychosocial Care

A QUALITATIVE STUDY EXPLORING MEANINGFUL IMPROVEMENT IN BOWEL URGENCY AMONG ADULTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS

Louise Newton and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S86–S87, https://doi.org/10.1093/ibd/izac015.140

• Abstract
• View article

CHANGE IN URGENCY STATUS AMONG ULCERATIVE COLITIS PATIENTS: UNDERSTANDING THE IMPACT OF TREATMENT CHANGES FROM THE COREVITAS INFLAMMATORY BOWEL DISEASE REGISTRY

Douglas Wolf and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S87, https://doi.org/10.1093/ibd/izac015.141

• Abstract
• View article

DECONSTRUCTING DISTRESS: STAKEHOLDER ENGAGEMENT FOR EVIDENCE-BASED, PATIENT-CENTERED INTERVENTIONS FOR THE MANAGEMENT OF IBD-ASSOCIATED PSYCHOLOGICAL DISTRESS

Courtney Heisler and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S88, https://doi.org/10.1093/ibd/izac015.142

• Abstract
• View article

EXPLORING SELF-MANAGEMENT CHALLENGES OF ADOLESCENTS AND YOUNG ADULTS WITH INFLAMMATORY BOWEL DISEASE IN AN ONLINE INSTAGRAM SUPPORT COMMUNITY

Caeli Malloy and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S88–S89, https://doi.org/10.1093/ibd/izac015.143

• Abstract
• View article

FEAR OF THE COVID-19 PANDEMIC IN ADOLESCENTS AND YOUNG ADULTS WITH INFLAMMATORY BOWEL DISEASE: RELATIONSHIP TO PSYCHOLOGICAL AND PHYSICAL OUTCOMES

Nicole Neiman and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S89–S90, https://doi.org/10.1093/ibd/izac015.144

• Abstract
• View article

FECAL CALPROTECTIN TESTING: AN INVESTIGATION OF PATIENT COMPLIANCE AND PERCEPTIONS

Courtney Perry and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S90, https://doi.org/10.1093/ibd/izac015.145

• Abstract
• View article

IDENTIFYING BARRIERS TO HEALTH MAINTENANCE IN MEDICALLY-UNDERSERVED PATIENTS WITH IBD: A QUALITATIVE STUDY

Juanita Belton and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S90–S91, https://doi.org/10.1093/ibd/izac015.146

• Abstract
• View article

INCREASED PREVALENCE OF ANXIETY IN HOSPITALIZED CROHN’S DISEASE PATIENTS IN THE UNITED STATES: INSIGHTS FROM NATIONAL INPATIENT DATABASE FROM 2009 TO 2018

Abhishek Bhurwal and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S91, https://doi.org/10.1093/ibd/izac015.147

• Abstract
• View article

LONGITUDINAL STUDY OF THE IMPACT OF HEALTH CONFIDENCE ON INFLAMMATORY BOWEL DISEASE OUTCOMES AND HEALTHCARE UTILIZATION

Chung Sang Tse and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S91–S92, https://doi.org/10.1093/ibd/izac015.148

• Abstract
• View article

PATIENTS’ PERSPECTIVES, EXPERIENCES, AND CONCERNS WITH CROHN’S PERIANAL FISTULAE: INSIGHTS FROM SOCIAL MEDIA PLATFORMS

Carine Khalil and others

Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S92–S93, https://doi.org/10.1093/ibd/izac015.149

• Abstract
• View article